secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001558370-24-013879
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q1 revenue $289.5M (organic +4%), adj EPS $0.42; declares $0.08 dividend
--------------------------------------------------------------------------------

- Q1 revenue $289.5M, up 5% reported (4% organic); GAAP EPS $0.21 vs $0.31; adjusted EPS $0.42 vs $0.41.
- Diagnostics & Spatial Biology segment organic growth 14%; cell and gene therapy workflow solutions strong.
- Dividend of $0.08 per share declared, payable Nov 22 to holders of record Nov 11.
- Annual meeting: board set at 9, all director nominees elected, say-on-pay approved, KPMG ratified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837024013879/0001558370-24-013879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837024013879/tech-20241025x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-013879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer